SAXENDA (liraglutide [rDNA origin] injection)

1 / 1
Share this content:

This slideshow reviews drug information for SAXENDA (liraglutide [rDNA origin] injection) indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult overweight or obese patients.

You must be a registered member of Renal and Urology News to post a comment.

Renal and Urology News Articles

Sign Up for Free e-newsletters